Aroa Biosurgery (ASX:ARX) — Material Events
ASX:ARX · 9 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Aroa Biosurgery Boosts Sales 14% and Returns to EBITDA Profit in H1 FY26Medium
Aroa Biosurgery H1 FY26 revenue up 14%, normalised EBITDA profit, reaffirms FY26 guidance
25 Nov 2025
·Interim Financial Report
·85
Aroa Biosurgery Surpasses FY26 Targets with NZ$104m Revenue and Eyes FY27 GrowthMedium
Aroa Biosurgery FY26 revenue NZ$104m beats guidance; EBITDA NZ$13m; Myriad sales +54%; Symphony RCT success
26 May 2026
·Full Year Results
·85
Aroa Biosurgery’s Symphony Trial Shows Promising Healing for Diabetic Foot UlcersMedium
Aroa Biosurgery completes Symphony RCT showing improved diabetic foot ulcer healing
30 Mar 2026
·Clinical Trial Completion Announcement
·85
Aroa Biosurgery’s Revenue Climbs 14% as EBITDA Turns Positive in H1 FY26Medium
Aroa Biosurgery H1 FY26 revenue up 14%, EBITDA turns positive; FY26 guidance reaffirmed
25 Nov 2025
·Half Year Financial Results
·80
Aroa Biosurgery Posts Record Myriad Sales and Confirms FY26 Growth OutlookMedium
Aroa Biosurgery posts strong cash flow, reaffirms FY26 guidance, and highlights US Medicare reimbursement opportunity
16 Oct 2025
·Quarterly Cash Flow Report and Commentary
·80
How Aroa Biosurgery’s Symphony and Myriad Are Shaping FY26 GrowthMedium
Aroa Biosurgery affirms FY26 guidance; CMS reimbursement supports Symphony; Myriad trauma study published
3 Feb 2026
·Business Update
·75
Aroa Biosurgery Secures Third Straight Quarter of Positive Cash FlowMedium
Aroa Biosurgery posts third consecutive positive cash flow quarter, reaffirms FY26 guidance
29 July 2025
·Quarterly Cash Flow Report and Activity Update
·75
Aroa Biosurgery Charts Growth Amid Clinical Wins and Reimbursement ShiftsMedium
Aroa Biosurgery reports positive clinical study results, evolving reimbursement landscape, and upward financial guidance for FY26
3 Feb 2026
·Business Update
·75
No articles in this tier for the last 12 months.
Market Mentions
7
- appeared in market wrap coverage
These are market wrap articles where Aroa Biosurgery (ASX:ARX) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Healthcare Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Market Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Market Wrap - Week 14 (30 Mar -> 3 Apr) 2026
4 Apr 2026